In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Serono to buy Genset

Executive Summary

Serono SA is buying French genomics firm Genset SA in an all cash offer of €107.4mm ($106mm). Genset shares trade in France on the Nouveau Marche and in the US on Nasdaq; the offering price represents a premium of 195% and 188%, respectively, over the market trading prices.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Partial Acquisition
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register